Aspirin and antiplatelet agent resistance: implications for prevention of secondary stroke. (Q37798798)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20932071%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

title

Aspirin and antiplatelet agent resistance: implications for prevention of secondary stroke (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20932071%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20932071%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

author name string

David M Greer

series ordinal

1

1 reference

23 August 2017

1 December 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20932071%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20932071%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

volume

24

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20932071%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

issue

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20932071%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

page(s)

1027-1040

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20932071%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.2165/11539160-0000000000-00000

15 February 2020

exact match

0 references

cites work

Increased blood plasma hydrolysis of acetylsalicylic acid in type 2 diabetic patients: a role of plasma esterases

1 reference

Crossref

https://api.crossref.org/works/10.2165%2F11539160-0000000000-00000

The effect of acetylsalicylic acid resistance on prognosis of patients who have developed acute coronary syndrome during acetylsalicylic acid therapy

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.2165%2F11539160-0000000000-00000

Near-field amplification of antithrombotic effects of dipyridamole through vessel wall cells

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.2165%2F11539160-0000000000-00000

A prospective, blinded determination of the natural history of aspirin resistance among stable patients with cardiovascular disease

21 January 2018

1 reference

12 December 2020

The effect of CYP2C19 polymorphism on the pharmacokinetics and pharmacodynamics of clopidogrel: a possible mechanism for clopidogrel resistance

1 reference

12 December 2020

Dipyridamole enhances NO/cGMP-mediated vasodilator-stimulated phosphoprotein phosphorylation and signaling in human platelets: in vitro and in vivo/ex vivo studies

1 reference

12 December 2020

Prevalence of persistent platelet reactivity despite use of aspirin: a systematic review

1 reference

12 December 2020

Assessment, mechanisms, and clinical implication of variability in platelet response to aspirin and clopidogrel therapy

1 reference

12 December 2020

Aspirin resistance and adverse clinical events in patients with coronary artery disease

1 reference

12 December 2020

Reticulated platelets and uninhibited COX-1 and COX-2 decrease the antiplatelet effects of aspirin

1 reference

12 December 2020

Relationship between endothelial dysfunction, oxidant stress and aspirin resistance in patients with stable coronary heart disease

1 reference

12 December 2020

Antithrombotic and thrombolytic therapy for ischemic stroke: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy

1 reference

12 December 2020

Clopidogrel resistance is associated with increased risk of recurrent atherothrombotic events in patients with acute myocardial infarction

1 reference

12 December 2020

Evaluation of dose-related effects of aspirin on platelet function: results from the Aspirin-Induced Platelet Effect (ASPECT) study

1 reference

12 December 2020

Aspirin Resistance in Patients with Stable Coronary Artery Disease with and without a History of Myocardial Infarction

1 reference

12 December 2020

Platelet function profiles in patients with type 2 diabetes and coronary artery disease on combined aspirin and clopidogrel treatment

1 reference

12 December 2020

Platelet aggregation and aspirin non-responsiveness increase when an acute coronary syndrome is complicated by an infection

1 reference

12 December 2020

The additive antiplatelet action of clopidogrel in patients with coronary artery disease treated with aspirin

1 reference

12 December 2020

A comparison of two doses of aspirin (30 mg vs. 283 mg a day) in patients after a transient ischemic attack or minor ischemic stroke

1 reference

12 December 2020

Aspirin noncompliance is the major cause of "aspirin resistance" in patients undergoing coronary stenting

1 reference

12 December 2020

Screening for aspirin responsiveness after transient ischemic attack and stroke: comparison of 2 point-of-care platelet function tests with optical aggregometry

1 reference

12 December 2020

Residual arachidonic acid-induced platelet activation via an adenosine diphosphate-dependent but cyclooxygenase-1- and cyclooxygenase-2-independent pathway: a 700-patient study of aspirin resistance

1 reference

12 December 2020

Adherence to secondary stroke prevention strategies--results from the German Stroke Data Bank

1 reference

12 December 2020

A comparison of six major platelet function tests to determine the prevalence of aspirin resistance in patients with stable coronary artery disease

1 reference

12 December 2020

Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation

1 reference

12 December 2020

Aspirin resistance: position paper of the Working Group on Aspirin Resistance

1 reference

12 December 2020

Increased basal platelet activity, plasma adiponectin levels, and diabetes mellitus are associated with poor platelet responsiveness to in vitro effect of aspirin

1 reference

12 December 2020

Aspirin esterase activity - Evidence for skewed distribution in healthy volunteers

1 reference

12 December 2020

Aspirin-resistant thromboxane biosynthesis and the risk of myocardial infarction, stroke, or cardiovascular death in patients at high risk for cardiovascular events

1 reference

12 December 2020

Variable platelet response to aspirin in patients with ischemic stroke

1 reference

12 December 2020

Aspirin dose for the prevention of cardiovascular disease: a systematic review

1 reference

12 December 2020

Cyclooxygenase inhibitors and the antiplatelet effects of aspirin

1 reference

12 December 2020

Pharmacogenetics of aspirin resistance: a comprehensive systematic review

1 reference

12 December 2020

Prevalence of aspirin resistance in patients with an evolving acute myocardial infarction

1 reference

12 December 2020

Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomised, double-blind, placebo-controlled trial

1 reference

12 December 2020

Prevalence and risk factors for aspirin and clopidogrel resistance in cerebrovascular stenting

1 reference

12 December 2020

Dual antiplatelet agent failure: a new syndrome or clinical nonentity?

1 reference

12 December 2020

Platelet function monitoring in patients with coronary artery disease

1 reference

12 December 2020

The antithrombotic profile of aspirin. Aspirin resistance, or simply failure?

1 reference

12 December 2020

Cytochrome p-450 polymorphisms and response to clopidogrel

1 reference

12 December 2020

Aspirin resistance: an evaluation of current evidence and measurement methods

1 reference

12 December 2020

1 reference

12 December 2020

Antiplatelet drug resistance and drug-drug interactions: Role of cytochrome P450 3A4

1 reference

12 December 2020

Towards a definition of aspirin resistance: a typological approach

1 reference

12 December 2020

Effects of the proton pump inhibitor lansoprazole on the pharmacokinetics and pharmacodynamics of prasugrel and clopidogrel

1 reference

12 December 2020

Update to the AHA/ASA recommendations for the prevention of stroke in patients with stroke and transient ischemic attack

1 reference

12 December 2020

Effect of high dose statin therapy on platelet function; statins reduce aspirin-resistant platelet aggregation in patients with coronary heart disease

1 reference

12 December 2020

Cytochrome P450 2C19 loss-of-function polymorphism is a major determinant of clopidogrel responsiveness in healthy subjects

1 reference

12 December 2020

Cardiac safety in the European Stroke Prevention Study 2 (ESPS2)

1 reference

12 December 2020

Influence of omeprazole on the antiplatelet action of clopidogrel associated with aspirin: the randomized, double-blind OCLA (Omeprazole CLopidogrel Aspirin) study

1 reference

12 December 2020

Aspirin and clopidogrel resistance

1 reference

12 December 2020

Effect of enteric coating on antiplatelet activity of low-dose aspirin in healthy volunteers

1 reference

12 December 2020

Cytochrome P450 2C19 loss-of-function polymorphism, but not CYP3A4 IVS10 + 12G/A and P2Y12 T744C polymorphisms, is associated with response variability to dual antiplatelet treatment in high-risk vascular patients.

1 reference

12 December 2020

Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients

1 reference

12 December 2020

Comparison of ticagrelor with clopidogrel in patients with a planned invasive strategy for acute coronary syndromes (PLATO): a randomised double-blind study

1 reference

12 December 2020

Clopidogrel for coronary stenting: response variability, drug resistance, and the effect of pretreatment platelet reactivity

1 reference

12 December 2020

Platelet function measured by VerifyNow identifies generalized high platelet reactivity in aspirin treated patients

1 reference

12 December 2020

Oral antiplatelet therapy in cerebrovascular disease, coronary artery disease, and peripheral arterial disease

1 reference

12 December 2020

No case of COX-1-related aspirin resistance found in 289 patients with symptoms of stable CHD remitted for coronary angiography

1 reference

12 December 2020

Can aspirin resistance be clinically predicted in stroke patients?

1 reference

12 December 2020

Antithrombotic and thrombolytic therapy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).

1 reference

12 December 2020

Aspirin non-responder status in patients with recurrent cerebral ischemic attacks

1 reference

12 December 2020

Contribution of gene sequence variations of the hepatic cytochrome P450 3A4 enzyme to variability in individual responsiveness to clopidogrel

1 reference

12 December 2020

Platelet-active drugs: the relationships among dose, effectiveness, and side effects: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy

1 reference

12 December 2020

Patients with poor responsiveness to thienopyridine treatment or with diabetes have lower levels of circulating active metabolite, but their platelets respond normally to active metabolite added ex vivo

1 reference

12 December 2020

Determination of aspirin responsiveness by use of whole blood platelet aggregometry

1 reference

12 December 2020

Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events

1 reference

12 December 2020

Screening for aspirin resistance in stable coronary artery patients by three different tests

1 reference

12 December 2020

Clopidogrel resistance: a new chapter in a fast-moving story

1 reference

12 December 2020

Effect of prasugrel versus clopidogrel on outcomes among patients with acute coronary syndrome undergoing percutaneous coronary intervention without stent implantation: a TRial to assess Improvement in Therapeutic Outcomes by optimizing platelet inh

1 reference

12 December 2020

Aspirin-induced platelet inhibition in patients undergoing cardiac surgery

1 reference

12 December 2020

Dipyridamole decreases protease-activated receptor and annexin-v binding on platelets of post stroke patients with aspirin nonresponsiveness

1 reference

12 December 2020

Flow cytometric assessment of vasodilator-stimulated phosphoprotein: prognostic value of recurrent cardiovascular events after acute coronary syndromes

1 reference

12 December 2020

Platelet activation in type 2 diabetes mellitus

1 reference

12 December 2020

Clinical implications of aspirin resistance

1 reference

12 December 2020

Internal analgesic, antipyretic, and antirheumatic drug products for over-the-counter human use; final rule for professional labeling of aspirin, buffered aspirin, and aspirin in combination with antacid drug products; technical amendments. Departm

1 reference

12 December 2020

Genetic determinants of response to clopidogrel and cardiovascular events

1 reference

12 December 2020

Lack of effect of enteric coating on aspirin-induced inhibition of platelet aggregation in healthy volunteers

1 reference

12 December 2020

Aspirin plus dipyridamole versus aspirin alone after cerebral ischaemia of arterial origin (ESPRIT): randomised controlled trial

1 reference

12 December 2020